Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manakamana Khanal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|August 7, 2015
Nanostructures for the Inhibition of Viral InfectionsSabine Szunerits, Alexandre Barras, Manakamana Khanal, et al.
Tissue Engineering. Part A|September 17, 2020
Degradation-Dependent Protein Release from Enzyme Sensitive Injectable Glycol Chitosan HydrogelShalini V Gohil, Aiswaria Padmanabhan, Ho-Man Kan, et al.
Nanoscale|December 16, 2014
Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entryManakamana Khanal, Alexandre Barras, Thibaut Vausselin, et al.
Clinical and Translational Medicine|November 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomasSameer Mir, Abhilash Venugopalan, Jingli Zhang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|March 18, 2015
Toward multifunctional "clickable" diamond nanoparticlesManakamana Khanal, Volodymyr Turcheniuk, Alexandre Barras, et al.
ACS Applied Materials & Interfaces|November 5, 2013
Phenylboronic-acid-modified nanoparticles: potential antiviral therapeuticsManakamana Khanal, Thibaut Vausselin, Alexandre Barras, et al.
Molecular Cancer Therapeutics|May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid TumorsSakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.
Acta Biomaterialia|May 28, 2018
Injectable nanocomposite analgesic delivery system for musculoskeletal pain managementManakamana Khanal, Shalini V Gohil, Emmanuel Kuyinu, et al.
Nanoscale|January 7, 2015
Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticlesManakamana Khanal, Fanny Larsonneur, Victoriia Raks, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2020
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase ExpressionDaniel Rathkey, Manakamana Khanal, Junko Murai, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|August 7, 2015
Nanostructures for the Inhibition of Viral InfectionsSabine Szunerits, Alexandre Barras, Manakamana Khanal, et al.
Tissue Engineering. Part A|September 17, 2020
Degradation-Dependent Protein Release from Enzyme Sensitive Injectable Glycol Chitosan HydrogelShalini V Gohil, Aiswaria Padmanabhan, Ho-Man Kan, et al.
Nanoscale|December 16, 2014
Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entryManakamana Khanal, Alexandre Barras, Thibaut Vausselin, et al.
Clinical and Translational Medicine|November 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomasSameer Mir, Abhilash Venugopalan, Jingli Zhang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|March 18, 2015
Toward multifunctional "clickable" diamond nanoparticlesManakamana Khanal, Volodymyr Turcheniuk, Alexandre Barras, et al.
ACS Applied Materials & Interfaces|November 5, 2013
Phenylboronic-acid-modified nanoparticles: potential antiviral therapeuticsManakamana Khanal, Thibaut Vausselin, Alexandre Barras, et al.
Molecular Cancer Therapeutics|May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid TumorsSakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.
Acta Biomaterialia|May 28, 2018
Injectable nanocomposite analgesic delivery system for musculoskeletal pain managementManakamana Khanal, Shalini V Gohil, Emmanuel Kuyinu, et al.
Nanoscale|January 7, 2015
Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticlesManakamana Khanal, Fanny Larsonneur, Victoriia Raks, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2020
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase ExpressionDaniel Rathkey, Manakamana Khanal, Junko Murai, et al.
Pageof 1